Protalix BioTherapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 33.8M | 9.1M | 17.9M | 15.7M | 10.1M | 18.2M | 18.0M | 13.5M |
| Cost of Goods Sold | 4.1M | 4.6M | 8.3M | 5.9M | 8.2M | 3.9M | 8.4M | 9.5M |
| Gross Profit | 29.6M | 4.5M | 9.5M | 9.8M | 1.9M | 14.3M | 9.6M | 4.0M |
| R&D Expenses | 5.4M | 5.6M | 4.5M | 6.0M | 3.5M | 4.1M | 3.0M | 3.0M |
| Operating Expenses | 8.5M | 9.2M | 7.4M | 8.6M | 6.1M | 7.1M | 5.6M | 6.4M |
| Operating Income | 21.1M | -4.7M | 2.1M | 1.2M | -4.1M | 7.2M | 4.0M | -2.4M |
| Other Income / Gains | -5K | -118K | 108K | -511K | 413K | 107K | -148K | 155K |
| Net Income | 18.3M | -5.5M | 2.4M | 164K | -3.6M | 6.5M | 3.2M | -2.2M |
| EPS (Diluted) | 0.23 | -0.069 | 0.03 | 0.002 | -0.047 | 0.089 | 0.044 | -0.03 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.878 | 0.494 | 0.534 | 0.625 | 0.191 | 0.787 | 0.534 | 0.298 |
| General And Administrative Expenses | -4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 7.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 3.1M | 3.5M | 2.9M | 2.6M | 2.6M | 3.0M | 2.6M | 3.5M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 12.6M | 13.8M | 15.7M | 14.5M | 14.3M | 11.0M | 14.0M | 15.9M |
| Interest Income | 188K | 265K | 288K | 272K | 419K | 113K | 151K | 522K |
| Interest Expense | 193K | 383K | 180K | 783K | 6K | 6K | 299K | 367K |
| Depreciation And Amortization | 404K | 387K | 372K | 360K | 346K | 334K | 329K | 319K |
| Ebitda | 21.7M | -4.0M | 2.8M | 1.8M | -3.4M | 7.7M | 4.5M | -1.6M |
| Ebitdaratio | 0.644 | -0.439 | 0.156 | 0.115 | -0.334 | 0.42 | 0.249 | -0.118 |
| Operating Income Ratio | 0.627 | -0.511 | 0.119 | 0.075 | -0.41 | 0.396 | 0.222 | -0.18 |
| Income Before Tax | 21.1M | -4.8M | 2.2M | 661K | -3.7M | 7.3M | 3.8M | -2.3M |
| Income Before Tax Ratio | 0.626 | -0.524 | 0.125 | 0.042 | -0.369 | 0.402 | 0.214 | -0.169 |
| Income Tax Expense | 2.8M | 728K | -116K | 497K | -113K | 822K | 607K | -69K |
| Net Income Ratio | 0.543 | -0.603 | 0.132 | 0.01 | -0.358 | 0.356 | 0.18 | -0.164 |
| Epsdiluted | 0.22 | -0.069 | 0.03 | 0.002 | -0.047 | 0.086 | 0.034 | -0.03 |
| Weighted Average Shs Out | 79.8M | 78.5M | 79.3M | 78.7M | 76.6M | 73.5M | 73.5M | 73.3M |
| Weighted Average Shs Out Dil | 83.0M | 78.5M | 80.8M | 81.3M | 76.6M | 81.1M | 81.2M | 73.3M |